Brokerages Set R1 RCM Inc. (NASDAQ:RCM) Target Price at $15.83

Shares of R1 RCM Inc. (NASDAQ:RCM) have received a consensus rating of “Moderate Buy” from the thirteen research firms that are presently covering the company, Marketbeat reports. Five investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $15.83.

RCM has been the subject of a number of analyst reports. Royal Bank of Canada restated an “outperform” rating and issued a $19.00 price target on shares of R1 RCM in a research note on Friday. Cantor Fitzgerald restated an “overweight” rating and issued a $20.00 price target on shares of R1 RCM in a research note on Wednesday, April 10th. KeyCorp restated a “sector weight” rating on shares of R1 RCM in a research note on Wednesday, April 10th. Canaccord Genuity Group decreased their price target on R1 RCM from $16.00 to $15.00 and set a “buy” rating for the company in a research note on Thursday, May 9th. Finally, Citigroup upgraded R1 RCM from a “neutral” rating to a “buy” rating and set a $16.00 price target for the company in a research note on Wednesday, March 20th.

Institutional Trading of R1 RCM

Several hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in R1 RCM by 5.6% in the 3rd quarter. Vanguard Group Inc. now owns 17,940,792 shares of the healthcare provider’s stock valued at $270,368,000 after acquiring an additional 947,310 shares in the last quarter. Capital International Investors raised its holdings in shares of R1 RCM by 0.8% during the 4th quarter. Capital International Investors now owns 8,343,199 shares of the healthcare provider’s stock worth $88,188,000 after buying an additional 67,485 shares in the last quarter. Voss Capital LLC raised its holdings in shares of R1 RCM by 553.9% during the 4th quarter. Voss Capital LLC now owns 7,125,000 shares of the healthcare provider’s stock worth $75,311,000 after buying an additional 6,035,340 shares in the last quarter. Invesco Ltd. raised its holdings in shares of R1 RCM by 4.4% during the 3rd quarter. Invesco Ltd. now owns 5,120,817 shares of the healthcare provider’s stock worth $77,171,000 after buying an additional 218,100 shares in the last quarter. Finally, Polar Capital Holdings Plc raised its holdings in shares of R1 RCM by 0.5% during the 3rd quarter. Polar Capital Holdings Plc now owns 4,696,412 shares of the healthcare provider’s stock worth $70,775,000 after buying an additional 22,550 shares in the last quarter. 61.10% of the stock is owned by institutional investors and hedge funds.

R1 RCM Stock Up 0.5 %

Shares of R1 RCM stock opened at $12.56 on Monday. The business’s 50 day simple moving average is $12.43 and its 200 day simple moving average is $11.88. R1 RCM has a 52-week low of $8.87 and a 52-week high of $18.70. The firm has a market cap of $5.29 billion, a PE ratio of -157.00 and a beta of 0.86. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.79 and a current ratio of 1.79.

R1 RCM (NASDAQ:RCM) last announced its earnings results on Wednesday, May 8th. The healthcare provider reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.03). R1 RCM had a negative net margin of 1.39% and a negative return on equity of 1.16%. The firm had revenue of $603.90 million during the quarter, compared to analyst estimates of $612.88 million. R1 RCM’s revenue was up 10.7% on a year-over-year basis. On average, analysts predict that R1 RCM will post -0.17 earnings per share for the current fiscal year.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.